The neurotrophin BDNF regulates the activity-dependent modifications of synaptic strength in the CNS. Physiological and biochemical evidences implicate the NMDA glutamate receptor as one of the targets for BDNF modulation. In the present study, we investigated the effect of BDNF on the expression and plasma membrane abundance of NMDA receptor subunits in cultured hippocampal neurons. Acute stimulation of hippocampal neurons with BDNF differentially upregulated the protein levels of the NR1, NR2A and NR2B NMDA receptor subunits, by a mechanism sensitive to transcription and translation inhibitors. Accordingly, BDNF also increased the mRNA levels for NR1, NR2A and NR2B subunits. The neurotrophin NT3 also upregulated the protein levels of NR2A and NR2B subunits, but was without effect on the NR1 subunit. The amount of NR1, NR2A and NR2B proteins associated with the plasma membrane of hippocampal neurons was differentially increased by BDNF stimulation for 30 min or 24 h. The rapid upregulation of plasma membrane-associated NMDA receptor subunits was correlated with an increase in NMDA receptor activity. The results indicate that BDNF increases the abundance of NMDA receptors and their delivery to the plasma membrane, thereby upregulating receptor activity in cultured hippocampal neurons.
Introduction
The neurotrophin brain-derived neurotrophic factor (BDNF) promotes neuronal survival and differentiation, and regulates synaptic transmission and plasticity (reviewed in Bramham and Messaoudi, 2005; Kalb, 2005; Lu et al., 2005) . BDNF rapidly potentiates excitatory synaptic transmission in cultured cerebrocortical and hippocampal neurons, in part by enhancing presynaptic neurotransmitter release (Lessmann and Heumann, 1998; Takei et al., 1998) . Post-synaptically, BDNF enhances glutamatergic synaptic transmission by regulating the phosphorylation of NMDA (N-methyl-D-aspartate) receptors (Suen et al., 1997; Lin et al., 1998; Alder et al., 2005) , thereby enhancing NMDA receptor activity Song et al., 1998) , increasing synaptic clustering of NMDA receptors in cultured hippocampal neurons (Elmariah et al., 2004) , and upregulating AMPA receptor protein levels (Narisawa-Saito et al., 1999a) . Accordingly, BDNF has been implicated in activitydependent synaptic plasticity, including the early-and late phases of long-term potentiation (LTP) induced by high-frequency stimulation (reviewed in Bramham and Messaoudi, 2005) . Activity-dependent changes in synaptic strength are thought to underlie learning and memory formation (Lynch, 2004) .
NMDA receptors are glutamate, glycine and voltage-dependent ion channels characterized by their high calcium permeability. In the hippocampus, NMDA receptors are heteromeric complexes composed of at least one NR1 subunit and one or more of the two subunits, NR2A and NR2B (Sheng et al., 1994) . Both NR1 and NR2 subunits are required to form a functional ionotropic receptor (Meguro et al., 1992; Monyer et al., 1994; Dingledine et al., 1999) , but different NR2 subunits confer distinct kinetic properties to the NMDA receptors (Monyer et al., 1994) . Some NMDA receptors may also include an NR3 subunit (either NR3A or NR3B) as part of the tetrameric structure (Chatterton et al., 2002) . Before synapse formation in developing hippocampal neurons, NMDA receptors consist predominantly of NR1 and NR2B subunits (Tovar and Westbrook, 1999) . NR2B seems to remain in NMDA receptors that are primarily extrasynaptic after synapse formation, although NR2B-containing NMDA receptors are also found at the synapse. This subunit composition is found in NMDA receptors present in synaptic and extrasynaptic regions after synapse formation. In contrast, NR2A subunit progressively increases its expression (Monyer et al., 1994; Sheng et al., 1994; Margottil and Domenici, 2003) and is incorporated at synaptic sites (Stocca and Vicini, 1998; Tovar and Westbrook, 1999) . The mechanisms controlling the switch in the composition of synaptic NMDA receptors from NR2B-to NR2A-containing receptors are not well understood (Barria and Malinow, 2002) , but studies in cortical neurons showed that the expression of NMDA receptor subunits is regulated by neuronal activity (Muzet and Dupont, 1996) .
BDNF enhances the phosphorylation of NR1 and NR2B subunits in hippocampal and cortical neurons (Lin et al., 1998) , and increases the open probability of NMDA receptor channels Levine and Kolb, 2000) . Phosphorylation of NR2B by Fyn was suggested to contribute to the increase of glutamatergic synaptic transmission by BDNF (Alder et al., 2005) , and tyrosine phosphorylation of the NR2B subunit was also associated with LTP in the hippocampal CA1 region (Nakazawa et al., 2001) . In addition to these rapid effects of BDNF on NMDA receptors, recent studies showed that BDNF increases the translation of the mRNA for NR1 in cultured cerebrocortical neurons (Schratt et al., 2004) , suggesting that the neurotrophin may also regulate the abundance of NMDA receptors in the hippocampus. Although NMDA receptors were initially thought to be relatively stable in the membrane, recent studies have indicated that their surface expression is dynamic and regulated (Nong et al., 2004) . Thus, the BDNF-induced upregulation of glutamatergic activity may also be due to the delivery of NMDA receptors to the plasma membrane. In the present study we investigated the short-and long-term effects of BDNF on the cellular and plasma membrane abundance of NMDA receptor subunits in cultured hippocampal neurons, and correlated the results with the effects of BDNF on the activity of the receptors.
Results

Effect of BDNF on the total protein levels of NMDA receptor subunits
To evaluate the acute effects of BDNF on the abundance of NMDA receptor subunits, 7 DIV cultured hippocampal neurons were incubated with or without 100 ng/ml BDNF, for various periods of time (15 min-24 h). The NMDA receptor subunit NR1, NR2A and NR2B protein levels were determined by Western Blotting (Figs. 1A, C and E). BDNF upregulated NR1 subunits rapidly and in a sustained manner. Significant effects were observed after 30 min to 12 h incubation with BDNF. The neurotrophin also did upregulate NR2A and NR2B subunits, but with a distinct kinetics. NR2A protein levels were significantly increased for longer periods of incubation with BDNF (3 h to 12 h), while NR2B protein levels were enhanced by brief BDNF stimulation periods (1 h to 3 h). After 24 h of stimulation with BDNF the NR1 and NR2A protein levels were still slightly higher than the control, whereas a small reduction of NR2B was observed. NR2C and NR2D subunits were undetectable (data not shown), consistent with the lack of these NMDA receptor subunits in the hippocampus (e.g. Janssens and Lesage, 2001) . BDNF also upregulated the amount of NR1, NR2A and NR2B subunits in more mature hippocampal neurons, cultured for 14 DIV (Fletcher et al., 1991; Figs. 1B, D and F) . In these cells BDNF induced a sustained increase in NR1 protein levels, particularly for incubation periods of 5 h, 6 h and 24 h. The NR2A subunit was also upregulated by BDNF for long periods of incubation with BDNF (6 h, 12 h and 24 h). In contrast, the NR2B subunit was upregulated only by short incubations with BDNF, as observed for 7 DIV (Fig. 1F) . Activation of Trk neurotrophin receptors was required for upregulation of NR1, NR2A and NR2B receptor subunits by BDNF, since no effect was observed when neurons were incubated with heat-inactivated BDNF ( Figs. 2A-C) . Furthermore, pre-incubation of hippocampal neurons with the Trk inhibitor K252a abrogated the effects of BDNF, although the inhibitor also upregulated the NR1 protein levels in the absence of neurotrophin (not shown).
In contrast with the results obtained with the hippocampal neurons, incubation of cultured cerebellar granule cells with 100 ng/ml BDNF, for 2 h or 6 h, did not increase the protein levels of NR1, NR2A and NR2B subunits (Figs. 2D-F) . These results indicate that the BDNF-induced upregulation of the NMDA receptor subunits is specific for hippocampal neurons.
Incubation of hippocampal neurons with a different neurotrophin, neurotrophin-3 (NT3), which binds preferentially to the TrkC receptors (Dechant, 2001) , also increased the protein levels of NR2A and NR2B subunits (Figs. 3B and C), but was without effect on NR1 subunit (Fig. 3A) , indicating that this neurotrophin also modulates the levels of the NMDA receptor subunits.
Since BDNF is known to upregulate translation (e.g. Takei et al., 2001 ) we studied whether de novo protein synthesis could account for the BDNF-induced increase in NR1, NR2A and NR2B NMDA receptor subunits. We used two translation inhibitors, emetine and anisomycin, and the hippocampal neurons were stimulated with BDNF for 3 h, in the presence or in the absence of the protein synthesis inhibitors. Pre-incubation of cells with emetine (2 μM) or anisomycin (2 μM) abolished the effect of BDNF on NR1, NR2A and NR2B subunits (Fig. 4) . None of the protein synthesis inhibitors altered the NR1, NR2A and NR2B protein levels under control conditions. These results are in agreement with the long half-life determined for the NR2A/B subunits in cultured cerebellar granule cells, and with the turn-over rate of NR1 in the same preparation (Huh and Wenthold, 1999) . Taken together, the results indicate that BDNF affects NMDA receptor subunits by increasing protein synthesis and suggest that a reduction in protein degradation is not involved.
Effect of BDNF in the transcription activity of NMDA receptor subunits
The effects of BDNF on protein synthesis may be due to an increase in transcription activity (Messaoudi et al., 2002) and/or to direct regulation of the protein synthesis machinery (Takei et al., 2001) . Therefore, the role of transcription in the BDNF-induced upregulation of NR1, NR2A and NR2B protein levels was investigated using two transcription inhibitors, α-amanitine and actinomycin D. As for the translation inhibitors, pre-incubation of the cultures with α-amanitine (1.5 μM) or actinomycin D (1.5 μM) abolished the BDNF-induced upregulation of the NR1, NR2A and NR2B protein levels, but was without effect on the abundance of the NMDA receptor subunits in the absence of BDNF (Fig. 5) . To further confirm that the effects of BDNF occur at the transcription level, real-time PCR using the SYBR green assay was performed (Fig. 6) . Stimulation with BDNF for 30 min or 3 h significantly increased the mRNA levels of NR1 and NR2A, although the effect was less significant in the latter incubation period. A delayed increase in the mRNA levels for NR2B was also observed after 3 h of stimulation with BDNF (Fig. 6) . These results point to a regulation of NR1, NR2A and NR2B NMDA receptor subunits by BDNF at the transcription level. Moreover, they clearly correlate the several fold increase in NR1 and NR2A mRNA with the sustained raise in the respective protein levels. On the other hand, the transient increase in NR2B protein levels induced by BDNF is also correlated with a relatively weaker effect on the mRNA levels of this specific subunit.
Effect of BDNF on NMDA receptor subunit protein levels at the plasma membrane
In cerebellar granule neurons there is a large intracellular pool of NR1 subunits, whereas most NR2A and NR2B subunit proteins are present on the cell surface (Huh and Wenthold, 1999) . Thus, in these cells the NR2 subunit availability determines the number of cell surface receptors (Prybylowski et al., 2002) . This may also apply to hippocampal neurons, where the majority of NR2B is associated with the plasma membrane, whereas a significant fraction of NR1 is intracellular (Hall and Soderling, 1997) . Therefore, we investigated whether the upregulation of NMDA receptor subunits by BDNF affects the NR1 and NR2 protein levels in the plasma membrane of cultured hippocampal neurons. The cell surface distribution of the NMDA receptor subunits NR1, NR2A and NR2B was determined by biotinylation of cell surface proteins, under control conditions and after treatment with 100 ng/ml BDNF. Surface proteins were then collected with streptavidin-coupled beads, and subjected to Western Blotting (Fig. 7) . BDNF treatment Fig. 1 . BDNF upregulates the protein levels of the NR1, NR2A and NR2B NMDA receptor subunits in cultured hippocampal neurons. Seven DIV (A, C, E) or 14 DIV (B, D, F) cultured hippocampal neurons were incubated with or without 100 ng/ml BDNF (15 min, 30 min, 1 h, 2 h, 3 h, 4 h, 5 h, 6 h, 12 h and 24 h), as indicated. Total NR1, NR2A and NR2B protein levels were determined by Western Blot. Control (0 h) protein levels of NMDA receptor subunits were set to 100%. β-tubulin was used as loading control. The results are the average ± S.E.M. of 5-9 independent experiments, performed in independent preparations. Statistical analysis was performed by one-way ANOVA, followed by the Dunnett's test. *P < 0.05, **P < 0.01. during 30 min markedly increased NR1 and NR2B proteins associated with the plasma membrane, whereas longer incubations with the neurotrophin (24 h) were required to significantly increase surface NR2A. These data suggest that BDNF differentially regulates the translocation of the NMDA receptors with different subunit compositions to the plasma membrane in cultured hippocampal neurons.
Effect of BDNF on the NMDA-induced [Ca 2+ ] i changes NMDA receptors are cation channels, permeable to Na + and Ca 2+ , and activation of these receptors increases the intracellular free calcium concentration ([Ca 2+ ] i ) (e.g. Duarte et al., 1996) . The effect of BDNF on the activity of NMDA receptors was investigated in single cultured hippocampal neurons, by Fura-2 imaging. Fig. 3 . Incubation of hippocampal neurons with NT3 increased the protein levels of NR2A and NR2B, but was without effect on NR1 protein levels. Seven DIV neurons were incubated with or without 100 ng/ml NT3 for 2 h and 6 h, and total NR1 (A), NR2A (B) and NR2B (C) protein levels were measured by Western Blot. Control (unstimulated) protein levels of NMDA receptor subunits were set to 100%. β-tubulin was used as loading control. The results are the average ± S.E.M. of 5-8 independent experiments, performed in independent preparations. Statistical analysis was performed by one-way ANOVA, followed by the Dunnett's test. *P < 0.05, **P < 0.01. Fig. 2 . Heat-inactivated BDNF does not upregulate NR1, NR2A or NR2B protein levels (A-C). Hippocampal neurons were incubated with or without 100 ng/ml heat-inactivated BDNF (95°C, 5 min), for 3 h. NR1, NR2A and NR2B protein levels were measured by Western Blot. BDNF does not affect the protein levels of NR1, NR2A and NR2B subunits in cultured cerebellar granule neurons (D-F). The cells were incubated with or without 100 ng/ml BDNF (2 h and 6 h), and the NR1, NR2A and NR2B protein levels were measured by Western blot. Control (unstimulated) protein levels of NMDA receptor subunits were set to 100%. β-tubulin was used as loading control. The results are the average ± S.E.M. of 4-9 independent experiments, performed in independent preparations. Statistical analysis was performed by one-way ANOVA, followed by the Dunnett's test.
Stimulation of cultured hippocampal neurons with NMDA, in a Mg 2+ -free medium, increased the Fura-2 fluorescence ratio (F340/ F380) (Fig. 8) . When the cells were pre-incubated with BDNF for 40 min there was an increase in the NMDA-induced [Ca 2+ ] i rise. The [Ca 2+ ] i response to activation of NMDA receptors is due to Ca 2+ entry through the receptor channels and to Ca 2+ influx through voltage-gated Ca 2+ channels (Duarte et al., 1996) . To determine whether the effect of BDNF on the responses to NMDA is due to an increase in the activity of voltage-gated Ca 2+ channels, rather than to a direct change in the activity of the receptors, we studied the effect of the neurotrophin on the initial [Ca 2+ ] i changes caused by KCl depolarization. Perfusion of the cells with a solution where NaCl was isoosmotically replaced by 30 mM KCl rapidly increased the [Ca 2+ ] i , but the magnitude of the response was not affected by Fig. 4 . Translation inhibitors impair the BDNF-induced upregulation of NR1, NR2A and NR2B protein levels. Seven DIV hippocampal neurons were incubated with or without 100 ng/ml BDNF for 3 h, in the presence or in the absence of emetine (2.0 μM) (A, C, E) or anisomycin (2.0 μM) (B, D, F). When the inhibitors were used the cells were pre-incubated with the compounds for 30 min before stimulation with BDNF. Total NR1, NR2A and NR2B protein levels were measured by Western Blot. Control protein levels of NMDA receptor subunits were set to 100%. β-tubulin was used as loading control. The results are the average ± S.E.M. of 6-12 independent experiments, performed in independent preparations. Statistical analysis was performed by one-way ANOVA, followed by the Dunnett's test. *P < 0.05, **P < 0.001.
pre-incubation of the cells with BDNF. Taken together, these results strongly suggest that the BDNF-induced increase in the [Ca 2+ ] i responses to NMDA are due, at least in part, to an upregulation of the plasma membrane-associated receptors.
Discussion
BDNF has been shown to play important roles in the regulation of the glutamatergic synaptic transmission and in the early-and latephases of LTP (reviewed in Bramham and Messaoudi, 2005) , but the underlying mechanisms are still not fully understood. The rapid effects of BDNF on the post-synaptic responses to glutamate have been largely attributed to the phosphorylation of NMDA receptor subunits, which increases receptor activity Levine and Kolb, 2000) . In the present study, we showed that BDNF also induces a rapid delivery of NR2B-containing NMDA receptors to the plasma membrane, which correlated with an increased [Ca 2+ ] i response to the activation of the receptors. Furthermore, we showed that BDNF differentially upregulates the NR1, NR2A and NR2B NMDA receptor subunits in cultured hippocampal neurons through Fig. 5 . Transcription inhibitors prevent the BDNF-induced upregulation of the NR1, NR2A and NR2B protein levels. Seven DIV cultured hippocampal neurons were incubated with or without 100 ng/ml BDNF for 3 h, in the presence or in the absence of α-amanitine (1.5 μM) (A, C, E) or actinomycin D (1.5 μM) (B, D, F). When the inhibitors were used the cells were pre-incubated with the compounds for 30 min before stimulation with BDNF. Total NR1, NR2A and NR2B protein levels were measured by Western Blot. Control protein levels of NMDA receptor subunits were set to 100%. β-tubulin was used as loading control. The results are the average ± S.E.M. of 5-10 independent experiments, performed in independent preparations. Statistical analysis was performed by one-way ANOVA, followed by the Dunnett's test. *P < 0.05.
an increase in transcription activity. The NT3, which binds to a different Trk receptor (TrkC), increased the protein levels of NR2A and NR2B subunits, but was without effect on NR1. The results showing the BDNF-induced rapid delivery of NR1 and NR2 subunits to the plasma membrane contribute to the growing evidence that the surface expression of NMDA receptors is dynamic and regulated Roche et al., 2001) , as previously documented for AMPA receptors (Gomes et al., 2003) . If BDNF has a similar effect on the delivery of NMDA receptors to the synapse, this may account, at least in part, for the role of the neurotrophin in synaptic plasticity. The delivery of NMDA receptors to the synapse plays an important role in long-term potentiation, although the NR2 subunit involved may depend on the development stage (Barria and Malinow, 2005; Kim et al., 2005) .
Stimulation of hippocampal neurons with BDNF induced a rapid delivery of NR1-and NR2B-containing NMDA receptors to the plasma membrane, but no increase in NR2A was observed for short incubations with the neurotrophin (Fig. 7) . This upregulation in plasma membrane-associated NMDA receptor subunits correlated with an increase in the [Ca 2+ ] i responses mediated by the receptor (Fig. 8) . The simultaneous effect on the delivery of NR1 and NR2 subunits was as expected, since both subunits are required to form a functional NMDA receptor (Meguro et al., 1992; Monyer et al., 1994; Dingledine et al., 1999) , and occurred at a time point when the amount of NR2B was still not significantly changed. The rapid effect of BDNF on the traffic of NR1/NR2B subunits changes the ratio of NR2A-and NR2B-containing NMDA receptors associated with the membrane, and is likely to result in slower excitatory postsynaptic currents (EPSCs) (Monyer et al., 1994) . Interestingly, a recent study showed that NR2B-containing receptors carry more calcium charge per unit current than NR2A-containing NMDA receptors (Sobczyk et al., 2005) , and we did observe an increased [Ca 2+ ] i response to NMDA in BDNF-treated hippocampal neurons (Fig. 8) .
BDNF was previously shown to acutely increase tyrosine phosphorylation of NR2B (but not NR2A) subunits in cortical and hippocampal postsynaptic densities (Lin et al., 1998) , and in cultured hippocampal neurons (Alder et al., 2005) , and the effect of the neurotrophin on the activity of NMDA receptors in cultured hippocampal neurons is sensitive to inhibitors of NR2B (Crozier et al., 1999; Levine and Kolb, 2000) . Our findings indicate that the upregulation of NR2B-containing receptors associated with the membrane accounts, at least in part, for the effect of the neurotrophin on the receptor activity, but the molecular mechanisms involved remain to be determined. The mechanisms mediating the effect of neurotrophins may be similar to those involved in insulininduced rapid delivery of NMDA receptors to the cell surface, since both receptors have tyrosine kinase activity. The effect of insulin occurs via a SNAP-25 mediated form of SNARE-dependent exocytosis, and does not require direct phosphorylation of the C-terminal tails of the receptor protein, but rather of associated targeting, anchoring, or signalling protein(s) ).
In addition to the effect resulting from the upregulation of plasma membrane-associated receptors, phosphorylation of NMDA receptors may also change their electrophysiological properties, and therefore may contribute to the change in activity induced by BDNF (Fig. 8) . BDNF acutely induces phosphorylation Fig. 6 . BDNF increases the mRNA levels of the NR1, NR2A and NR2B NMDA receptor subunits. The variation of NR1, NR2A and NR2B mRNA levels was assayed by SYBR Green real-time PCR of total RNA samples, converted to cDNA in reactions normalized to contain equal amounts of mRNA. The cells (7 DIV) were incubated in the presence or in the absence of 100 ng/ml BDNF, during 30 min (gray columns) or 3 h (black columns). The results are presented as mean percentage ± S.E.M. compared to the control (unstimulated), and normalized to the reference gene 18S, and are the average ± S.E.M. of 3-7 independent experiments, performed in independent preparations. Statistical analysis was performed by one-way ANOVA, followed by the Dunnett's test. **P < 0.01, ***P < 0.001. Fig. 7 . BDNF increases the NR1, NR2A and NR2B subunits in the plasma membrane. Neurons were treated with or without 100 ng/ml BDNF (30 min, 3 h and 24 h). Following treatment, cell surface proteins were labelled by biotinylation, followed by precipitation with streptavidin beads. The abundance of each subunit in the plasma membrane was then determined by Western Blot. Control (0 h) expression of NMDA subunits protein was set to 100%. The transferrin receptor was used as loading control. The results are the average ± S.E.M. of 3-8 independent experiments, performed in independent preparations. Statistical analysis was performed by one-way ANOVA, followed by the Dunnett's test. *P < 0.05, **P < 0.01. of NR1 and NR2B subunits in rat hippocampal postsynaptic densities (Suen et al., 1997; Lin et al., 1998; Alder et al., 2005) , and increases NMDA single channel open probability in cultured hippocampal neurons Levine and Kolb, 2000) . Phosphorylation of NR2B may be mediated by Fyn, a member of the Src family, since this kinase is activated by TrkB receptors (Narisawa-Saito et al., 1999b), and increases currents mediated by recombinant NMDA receptor (Kohr and Seeburg, 1996) . The activity of NMDA receptors in CNS neurons was also shown to increase following intracellular application of recombinant Src (Wang and Salter, 1994; Kalia et al., 2004; Salter and Kalia, 2004) , and Fyn-mediated interaction between BDNF signaling and NMDA receptors may play an important role in spatial learning and memory (Mizuno et al., 2003) . The signalling activity induced by BDNF may also affect NMDA receptors through protein kinase C, which modulates NMDA receptor trafficking and gating in cultured hippocampal neurons . In fact, activation of Trk receptors promotes PLCγ activity (Chao, 2003) , giving rise to diacylglicerol which activates PKC.
In contrast with the short-term effects of BDNF on the surface expression of NR1 and NR2B subunits, longer incubations with BDNF (24 h) increased the amount of NR2A subunits associated with the plasma membrane, but not of NR2B, further indicating that the traffic of the two subunits to the membrane is differentially affected by the neurotrophin. The delayed increase in NR2A in the membrane induced by BDNF may be secondary to the upregulation of the subunit induced by BDNF (Fig. 1 ) and/or due to changes in abundance of regulatory, motor or anchoring proteins that regulate the traffic of the receptor, since after 24 h of stimulation of the Trk receptors with the neurotrophin the receptors are no longer active (Almeida et al., 2005) . However, it was surprising not to observe an increase of NR1 associated with the membrane, together with NR2A, after long incubations with BDNF. Although this may suggest that the delivered receptors contain more NR2A than NR1 subunits, this hypothesis is against evidences suggesting that the NMDA receptor channels are formed as dimers of dimers (an NR1 dimmer and a NR2 dimmer) (Schorge and Colquhoun, 2003) . This BDNF-induced upregulation of NR2A associated with the plasma membrane after long incubation periods with the neurotrophin resembles the shift from NR2B to NR2A observed in developing neurons (Watanabe et al., 1992; Sheng et al., 1994; Barria and Malinow, 2002; Erisir and Harris, 2003; Kobayashi et al., 2006) , resulting in faster excitatory postsynaptic currents (EPSCs) and lower sensitivity to NR2B-selective antagonists (Carmignoto and Vicini, 1992; Flint et al., 1997) . This change is also thought to contribute to the developmental changes in NMDA-receptor mediated plasticity at glutamatergic synapses (Philpot et al., 2001) .
In addition to the translocation of NMDA receptor subunits to the plasma membrane, we also found that BDNF upregulated NR1, NR2A and NR2B subunits, by a mechanism involving transcription activation. This is supported by the results showing an increase in the mRNA levels for the three subunits in hippocampal neurons stimulated with BDNF (Fig. 6 ) and the inhibition of neurotrophininduced upregulation of NR1, NR2A and NR2B in the presence of transcription inhibitors (Fig. 5) . Therefore, although Trk receptor activation by neurotrophins may stimulate protein synthesis directly (Takei et al., 2004) , without transcription induction, this mechanism is not involved in the upregulation of NMDA receptor subunits by BDNF in hippocampal neurons. The effects of BDNF on NMDA receptor subunits were transient in 7 DIV cultures, most likely due to the desensitization of the Trk receptors, followed by a decrease in the intracellular signalling activity (Sommerfeld et al., 2000; Almeida et al., 2005) . However, in 14 DIV cultures BDNF induced a sustained increase in the NR1 and NR2A protein levels, but not of NR2B (Fig. 1) , which may be due to a change in the turn-over rate of the subunits in the more mature cultures. Interestingly, the expression of NR2A but not NR2B subunit is markedly reduced in the developing cortex of BDNF knockout mice (Margottil and Domenici, 2003) . NR1 expression is regulated by different transcription factors, including the NF-kappaB (Liu et al., 2004) or CREB (Lau et al., 2004) , and the latter is a major mediator of neuronal neurotrophin responses (Finkbeiner et al., 1997) . NR2B expression is also regulated by CREB (Rani et al., 2005) , in addition to AP-1 , which may also be activated by BDNF-induced signalling (Li et al., 2004) . Neurotrophin-4/5 was shown to upregulate NR2A through the immediate early transcription factor Egr-1 in cultured cerebrocortical neurons (Choi et al., 2004) .
Stimulation of hippocampal neurons with NT3 for 6 h also upregulated NR2A and NR2B protein levels, but was without effect on NR1. In contrast with the effect of BDNF, NT3 did not change the NMDA receptor subunit protein levels when 2 h of incubation ] i responses were set to 100%. The results are the average ± S.E.M. of 3-4 independent experiments, performed in independent preparations. Each experimental condition was performed in duplicate, and about 80-100 cells were analysed in each field of the microscope. Statistical analysis was performed using the Student's t test. **P < 0.01.
with the neurotrophin was used. Although the effects of both neurotrophins are likely mediated by Trk receptors (TrkB and TrkC, respectively) the differential responses may be due to a distinct cellular localization of the receptors and/or to differences in the magnitude of the signalling responses induced.
The BDNF-induced upregulation of NMDA receptor subunits and activity that we observed in cultured hippocampal neurons contrast with the lack of effect of BDNF in cerebellar granule neurons incubated with the neurotrophin for 2 h or 6 h (Figs. 2D-F) , indicating that BDNF has a specific effect on hippocampal neurons. These results contrast with the previously reported downregulation of the NR2A receptor subunits evoked by BDNF in cerebellar granule neurons (Brandoli et al., 1998) . This discrepancy may be due to differences in the composition of the culture medium, as well as the use of a distinct concentration of BDNF.
In addition to the long-term effects of BDNF on the abundance and surface expression of NMDA receptors reported in this work, the neurotrophin was also shown to increase the NMDA receptor cluster density and size in cultured hippocampal neurons (Elmariah et al., 2004) . Long-term stimulation of cultured cerebrocortical neurons with BDNF also upregulated AMPA receptor subunits and currents (Narisawa-Saito et al., 2002; Nagano et al., 2003) , indicating that the neurotrophin has an overall stimulatory effect on excitatory synapses. In contrast with the effects on excitatory synapses, BDNF was shown to reduce rapidly the surface expression of GABA A receptors and GABAergic currents in cultured hippocampal neurons (Brunig et al., 2001 ).
In conclusion, our work shows that BDNF differentially upregulates the plasma membrane associated NMDA receptors, and the protein levels of the receptor subunits in cultured hippocampal neurons. NMDA receptors play an important role in synaptic plasticity, and there is a selective activation of NMDA receptors in specific circuits during memory formation (Tang et al., 1999; Lynch, 2004) . The activation of NMDA receptors, together with non-NMDA receptors, induces the synthesis and release of BDNF (Zafra et al., 1990; Hughes et al., 1993) which may further promote NMDA receptor activity by increasing the number of receptors associated with the membrane. The resulting increase in calcium entry through the NMDA receptors will also regulate numerous other downstream signalling pathways, leading to both short-term and long-term neuronal changes (Hardingham and Bading, 2003) . If BDNF induces a rapid synaptic delivery of NR2B-containing receptors to the synapse, similarly to the effect observed on the overall surface expression of NMDA receptor subunits, this may be important to allow binding of active CaMKII to synaptic NMDA receptors, thereby contributing to synaptic potentiation (Barria and Malinow, 2005) . This model, proposed for developing synapses, contrasts with the role played by NR2A-NMDA receptors in promoting surface expression of GluR1-containing AMPA receptors (Kim et al., 2005) , a key event in LTP in more mature synapses (Malinow and Malenka, 2002) . Interestingly, BDNF also caused a delayed increase in NR2A associated with the plasma membrane.
Experimental methods
Hippocampal cultures
Primary cultures of rat hippocampal neurons were prepared from the hippocampi of E18-E19 Wistar rat embryos, after treatment with trypsin (0.06%, 15 min, 37°C; GIBCO Invitrogen, Paisley, UK) and deoxyribonuclease I (5.36 mg/ml), in Ca 2+ -and Mg 2+ -free Hank's balanced salt solution (HBSS; 5.36 mM KCl, 0.44 mM KH 2 PO 4 , 137 mM NaCl, 4.16 mM NaHCO 3 , 0.34 mM Na 2 HPO 4 .2H 2 O, 5 mM glucose, 1 mM sodium pyruvate, 10 mM HEPES and 0.001% phenol red). The hippocampi were then washed with HBSS containing 10% fetal bovine serum (BioWittaker Europe, Belgium), to stop trypsin activity, and transferred to Neurobasal medium (GIBCO Invitrogen) supplemented with B27 supplement (1:50 dilution; GIBCO Invitrogen), 25 μM glutamate, 0.5 mM glutamine and 0.12 mg/ml gentamycin. The cells were dissociated in this solution and were then plated in 6 well plates (91.6 × 10 3 cells/cm 2 ), coated with poly-D-lysine (0.1 mg/ml), or on poly-D-lysine coated glass coverslips, at a density of 37.5 × 10 3 cells/cm 2 . The cultures were maintained in a humidified incubator of 5% CO 2 /95% air, at 37°C, for 7 days or 14 days. Cultures were stimulated with 100 ng/ml BDNF (kind gift from Regeneron, Tarrytown, NY), 100 ng/ml heat inactivated (5 min, 95°C) BDNF or with 100 ng/ml NT3 (Peprotech, London U.K.) for the indicated periods of time. When appropriate, 2.0 μM emetine, 2. 0 μM anisomycin, 1.5 μM α-amanitine or 1.5 μM actinomycin D (Calbiochem, La Jolla, CA) were added 30 min before stimulation, as indicated.
Cerebellum cultures
Cerebellar granule neurons were isolated from the cerebella of 7-dayold Sprague-Dawley rats as previously described (Schousboe et al., 1989) , with minor modifications. Briefly, following digestion (15 min, 37°C) with 0.2% trypsin and 0.045 mg/ml deoxyribonuclease (Sigma) in Mg 2+ -free Na + -salt solution (120 mM NaCl, 5 mM KCl, 1.2 KH 2 PO 4 , 13 mM glucose,15 mM HEPES, 0.3% BSA, pH 7.4), and dissociation in 0.03% STI (soybean trypsin inhibitor; Sigma) and 0.04 mg/ml deoxyribonuclease prepared in Na + -salt solution (120 mM NaCl, 5 mM KCl, 1.2 KH 2 PO 4 , 1.2 mM MgSO 4 , 13 mM glucose,15 mM HEPES, 0.3% BSA, pH 7.4), the dissociated cells were centrifuged at 196×g, and washed with Basal Medium Eagle (BME, Sigma), supplemented with 25 mM KCl, 30 mM glucose, 26 mM NaHCO 3 , 100 U/ml penicillin, 0.1 mg/ml streptomycin and 10% fetal calf serum (BioWittaker Europe). Neurons were then plated on 6 well plates (34.4 × 10 4 cells/cm 2 ), coated with poly-D-lysine (0.1 mg/ ml), and cultured in supplemented BME. Approximately 24 h after plating, 10 μM cytosine-1-β-D-arabino-furanoside (Sigma) was added to the culture medium to prevent glial proliferation. The cultures were maintained in a humidified incubator of 5% CO 2 /95% air, at 37°C, for 8 days. Cultures were stimulated with 100 ng/ml BDNF (kind gift from Regeneron) for the indicated periods of time.
Preparation of extracts
Hippocampal and cerebellar granule neurons were washed twice with ice-cold PBS and once more with PBS buffer supplemented with 1 mM DTT and a cocktail of protease inhibitors (0.1 mM PMSF, CLAP: 1 μg/ml chymostatin, 1 μg/ml leupeptin, 1 μg/ml antipain, 1 μg/ml pepstatin; Sigma-Aldrich Química, Sintra, Portugal). The cells were then lysed with RIPA (150 mM NaCl, 50 mM Tris-HCl, pH 7.4, 5 mM EGTA, 1% Triton, 0.5% DOC and 0.1% SDS at a final pH 7.5) supplemented with the cocktail of protease inhibitors. After centrifugation at 16,100×g for 10 min, protein in the supernatants was quantified using the BCA method, and the samples were denaturated with 2× concentrated denaturating buffer (125 mM Tris, pH 6.8, 100 mM glycine, 4% SDS, 200 mM DTT, 40% glycerol, 3 mM sodium orthovanadate, and 0.01% bromophenol blue), at 95°C for 5 min. NMDA receptor subunits were then analysed by Western Blot.
Total RNA isolation and reverse transcription for Real-Time PCR Total RNA from 7 DIV cultured hippocampal neurons was extracted with TRizol reagent (Invitrogen, Barcelona, Spain), according to the instructions of the manufacturer. The full content of a 6 well cell cluster plate, with 870,000 cells/well (DIV 7), was collected for each experimental condition. For first strand cDNA synthesis, 3 μg of total RNA were reversetranscribed with AMV Reverse Transcriptase (Roche, Carnaxide, Portugal) , using Random Primer p(dN) 6 (3.2 μg), dNTPs (1 mM each), MgCl 2 (25 mM), RNase inhibitor (50 units) and Gelatine (0.01 μg/μl), in Reaction Buffer (10 mM Tris, 50 mM KCl, pH 8.3) and in a total volume of 40 μl. The reaction was performed at 25°C for 10 min, followed by 60 min at 42°C, for primer annealing to the RNA template and cDNA synthesis, respectively. The Reverse Transcriptase was then denatured during 5 min at 99°C, and the sample was cooled to 4°C for 5 min and finally stored at −80°C until further use.
Real-Time PCR
Real-Time PCR analysis of gene expression was performed using the LightCycler System II (Roche, Portugal) . The PCR reactions were performed using LightCycler FastStart DNA Master SYBR Green I (Roche et al.) in 20 μl capillaries. The primers used for amplification of genes encoding NMDA receptor subunits were, respectively, RNFRIF2079-5′ TAC ACT GCC AAC TTG GCA GCT TTC3′ and RNRIR2591-5′CAT GAA GAC CCC TGC CAT GTT3′ for NR1, RNRZAF1961-5′TGG CTG CCT TCA TGA TCC A3′ and RNRZAR2312-5′TGC AGC GCA ATT CCA TAG C3′ for NR2A, and RNRZBF1040-5′GGA TCT ACC AGT CTA ACA TG3′ and RIRNRZBR1602-5′GAT AGT TAG TGA TCC CAC TG3′ for NR2B. The primers used for the amplification of endogenous control gene 18S rRNA were those included in the Applied Biosystems TaqMan Ribosomal RNA Control Reagents Kit (Porto, Portugal). Each primer of a pair was added to the reaction mixture (10 μl) at a final concentration of 0.8 μM with 3 mM MgCl 2 , in addition to the "Hot Start" LightCycler Fast Start DNA Master SYBR Green I mix (1×) and 1. 2 μl of cDNA sample. Thermal cycling was initiated with activation of the FastStart Taq DNA Polymerase by denaturation during 10 min at 95°C, followed by 45 cycles of a 30 s melting step at 95°C, a 5 s annealing step at 58°C, and a 25 s elongation step at 72°C (all temperature transition rates at 20°C/s). After amplification for 45 cycles, at least 10 cycles beyond the beginning of the linear phase of amplification, samples were subjected to a melting curve analysis according to the instructions of the manufacturer in order to confirm the absence of unspecific amplification products and primer-dimers. In all experiments, samples containing no template were included as negative controls.
mRNA quantitative analysis
The mRNA levels of the constitutively expressed housekeeping gene encoding 18S ribosomal RNA were used as a control, in all experiments. The relative changes in the mRNA levels of glutamate receptor subunits in cultured hippocampal neurons were determined using the ΔΔCp method. Accordingly, for each experimental condition (unstimulated neurons and neurons treated with 100 ng/ml BDNF for 30 min or 3 h) the "Crossing point" (Cp) values given by the LightCycler system II software, for each target gene, were subtracted by the respective Cp value determined for the 18S gene for the same sample and condition (ΔCp). This allows normalizing changes in target gene expression. Afterwards, the ΔCp values were subtracted by the respective values of the control for the target gene giving ΔΔCp. The derivation to the formula 2 − (ΔΔCp) sets each control at the unity (or 100%), since ΔΔCp (control) = 0 and the stimuli conditions used were at a percentage relative to the control.
Surface biotinylation and precipitation
Hippocampal cell cultures (7 DIV) were treated or not with 100 ng/ml BDNF and then incubated with 1 mg/ml EZ-Link TM Sulfo-NHS-SS-biotin (Pierce, Madison, WI) in ice-cold PBS containing 1 mM CaCl 2 and 1 mM MgCl 2 , for 30 min (Gomes et al., 2004) . The non-bound biotin was removed by washing the cells with PBS containing 100 mM glycine. Cell lysates were obtained as described above, and were incubated with UltraLink Plus™ immobilized streptavidin beads (Pierce), for 2 h at 4°C, under constant agitation. Non-biotinylated proteins were removed by centrifugation at 2500×g for 3 min, and the beads were washed three times with RIPA buffer. Biotinylated proteins were then eluted with denaturating buffer at 95°C for 5 min. Samples were then processed for Western Blotting analysis.
Western blotting
Protein samples were separated by SDS-PAGE, in 6% polyacrylamide gels, transferred to polyvinylidene (PVDF) membranes (BioRad, Amadora, Portugal), and immunoblotted. Blots were incubated with primary antibodies (overnight at 4°C), washed and exposed to alkaline phosphatase-conjugated secondary antibodies (1:20000 dilution; 1 h at room temperature). Alkaline phosphatase activity was visualized by ECF on the Storm 860 Gel and Blot Imaging System (Amersham Biosciences, Buckinghamshire, UK). The following primary antibodies were used: anti-NR1 (1:200, Chemicon International, Temecula, CA), anti-NR2A (1:750, Chemicon International, Temecula, CA or 1:300, BD Transduction Laboratories, Erembodegem, Belgium) and anti-NR2B (1:400, BD Transduction Laboratories). Anti-β-Tubulin I (1:700,000; Sigma) and anti-transferrin receptor (1:3000; Zymed, South San Francisco, CA) antibodies were used as loading controls.
Single cell [Ca 2+ ] i measurements
Changes in the [Ca 2+ ] i were assessed by monitoring the Fura-2 (Invitrogen-Molecular Probes, Leiden, The Netherlands) fluorescence ratio (F340/F380). Seven DIV hippocampal neurons were loaded in a Mg 2+ -free Na + -salt solution (132 mM NaCl, 4 mM KCl, 2.5 mM CaCl 2 , 6 mM Glucose, 10 mM Hepes, 10 mM NaHCO 3 , pH 7.4) containing 5 μg/ml Fura-2/AM, 0.2% pluronic acid F-127 (Invitrogen-Molecular Probes) and 0.1% fatty acid-free bovine serum albumin, in the presence or absence of 100 ng/ml BDNF, for 40 min at 37°C. After incubation, the glass coverslips were mounted on a RC-20 chamber in a PH3 platform (Warner Instruments, Hamden, CT), at room temperature, on the stage of an inverted fluorescence microscope Axiovert 200 (Zeiss). Neurons were continuously perfused with a Mg 2+ -free Na + -salt solution, for 5 min, and were then stimulated with 100 μM NMDA and 10 μM glycine, or with 30 mM KCl (Na + was isoosmotically replaced by KCl), for 30 s. After stimulation neurons were again perfused with a Mg 2+ -free Na + -salt solution, for 10 min. Solutions were added to the cells by a fast-pressurized (95% air, 5% CO 2 atmosphere) system (AutoMate Scientific Inc, San Francisco, CA). The cells were alternately excited at 340 and 380 nm using a Lambda DG4 apparatus (Sutter Instruments Company, Novato, CA). Changes in the fluorescence ratio of Fura-2 were acquired with a 40× objective and a CollSNAP HQ digital camera (Roper Scientific, Tucson, AZ), and processed using the MetaFluor software (Universal Imaging Corporation, Downingtown, PA). The results are presented as the ratio of fluorescence intensities after excitation at 340 nm and at 380 nm.
Statistical analysis
Statistical analysis was performed using one-way ANOVA analysis of variance followed by the Dunnett's test, or Bonferroni test, or using the Student's t test, as indicated in the figure captions.
